🌎 Advanced Micro Devices Upgraded, NVIDIA Initiated, Lam Research Initiated and more...

Ratings changes for Advanced Micro Devices, CoreWeave, NVIDIA, JD.com, Equinix, Bitdeer Technologies Group, Nurix Therapeutics and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more.  Start Your Free Trial. Unsubscribe. View My Portfolio July 10th, 2025     EXPOSED: How Wall Street Algorithms Hijacked the Market During Tariff Chaos (ad) During last month's historic market swings, most investors panicked. But a small group of traders calmly watched their accounts grow. They were using Professor Jeff Bierman's "Genesis Cog" system to spot stocks being hijacked by institutional algorithms—before the moves happened.   See how they used this strategy to profit during extreme volatility. Today's Top Stories Buffett's $2B+ Bet With Big Long-Term Potential Just Got Upgraded By Leo Miller  |  July 10, 2025 07:41 AM How Early Investors Spot the Next Big Breakout Stocks  (Ad) By Market Pulse Today AI Chip Arms Race: 3 Must-Watch Equipment Stocks By Chris Markoch  |  July 10, 2025 06:44 AM Wall Street is off to a sluggish start while Delta soars on stronger outlook By The Associated Press  |  July 9, 2025 11:37 PM Trump's Exec Order #14154 could be a "Millionaire-Maker"  (Ad) By Paradigm Press Rubio says U.S. and Russia have exchanged new ideas for Ukraine peace talks By The Associated Press  |  July 9, 2025 10:05 PM Tesla Stock Could Accelerate on New EV Tax Legislation By Gabriel Osorio-Mazilli  |  July 9, 2025 03:34 PM Quick Links Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Screener Calculators Premium Reports Buy Stock Name your price for $2,000+ trading course (industry first) (ad) After 20+ years in the industry — including stints at ThinkorSwim and TD Ameritrade — this trader is throwing out the rulebook. He's inviting everyday traders into his live trading room to watch his team work in real time… and then letting you decide what the education is worth. No $5,000 price tag. No $997 paywall. Just one free trade, full access — and your call on the price.   Grab your free trade + name your price access here Your Watchlist Manage Your Watchlist and Monitor Your Portfolio   Apple Inc. (AAPL) (7/10) Evercore Holds Firm on Apple (gurufocus.com) (7/10) Supply-Chain Guru Becomes Apple's COO (gurufocus.com) (7/10) AAPL COURT NOTICE: Apple Inc. Investors may have been Affected by Fraud – Contact BFA Law by the August 19 Legal Deadline (NASDAQ:AAPL) (globenewswire.com) (7/10) Could Apple Soon Lose Its Top Position in Warren Buffett's Portfolio? (finance.yahoo.com) (7/10) Apple (AAPL) Chooses Not to Compete with Meta's Lucrative $200M Offer | AAPL Stock News (gurufocus.com)   Amazon.com, Inc. (AMZN) Amazon.com (NASDAQ:AMZN) had its "outperform" rating reaffirmed by Telsey Advisory Group (    ) (analyst Joseph Feldman). They now have a $235.00 price target on the stock. This represents a 5.6% upside from the current price of $222.54. (7/10) Amazon Reportedly Mulling New Multibillion-Dollar Anthropic Investment (pymnts.com) (7/10) Amazon Deals Fuel E-Commerce Boom (gurufocus.com) (7/10) Amazon (AMZN) Rating and Price Target Unchanged by Telsey Advisory Group | AMZN Stock News (gurufocus.com) (7/10) Amazon.com's (AMZN) Outperform Rating Reiterated at Telsey Advisory Group (marketbeat.com) (7/10) Confessions Of A Dividend Investor: 3 Growth Stocks I Secretly Wish I Owned Already (seekingalpha.com)   Alphabet Inc. (GOOGL) (7/10) The Hidden Quantum Computing Stock Wall Street Can't Get Enough Of (247wallst.com) (7/10) Roth Capital Has Bullish Estimate for Alphabet Q2 Earnings (marketbeat.com) (7/10) Turkey's competition board imposes $8.9 million fine to Google (reuters.com) (7/10) 4 Top Stocks to Buy for the Second Half of 2025 (fool.com) (7/10) Alphabet Inc. (NASDAQ:GOOGL) Shares Acquired by Values Added Financial LLC (marketbeat.com)   Meta Platforms, Inc. (META) COO Javier Olivan sold 517 shares of the firm's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $717.51, for a total value of $370,952.67. Following the completion of the sale, the chief operating officer owned 7,336 shares of the company's stock, valued at $5,263,653.36. This trade represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. (7/10) Meta poached Apple's AI engineer Pang with pay package over US$200 million: sources (businesstimes.com.sg) (7/10) Will Meta Platforms' New Superintelligence Labs Division Send the Stock Soaring to New Heights? (msn.com) (7/10) Roth Capital Expects Stronger Earnings for Meta Platforms (marketbeat.com) (7/10) More than 90% of X's Community Notes are never published and 'stuck in limbo', study finds (fortune.com) (7/10) Is Meta's $14.3 Billion Bet on Scale AI Too Little, Too Late? (fool.com)   Microsoft Corporation (MSFT) Microsoft (NASDAQ:MSFT) had its price target raised by Piper Sandler (    ) (analyst Brent Bracelin) from $475.00 to $600.00. They now have an "overweight" rating on the stock. This represents a 19.8% upside from the current price of $500.92. (7/10) Piper Sandler Raises Microsoft (NASDAQ:MSFT) Price Target to $600.00 (marketbeat.com) (7/10) Why Microsoft Keeps Showing Up in Congressional Portfolios (marketbeat.com) (7/10) BMO Capital Boosts Microsoft (MSFT) Price Target Following Positive Azure Outlook | MSFT Stock News (gurufocus.com) (7/10) Analyzing Microsoft Corporation's (MSFT) Strategic Journey in AI Revolution (finance.yahoo.com) (7/10) Analyzing Microsoft Corporation's (MSFT) Strategic Journey in AI Revolution (insidermonkey.com) Manage Your Watchlist Analysts' Upgrades Advanced Micro Devices (NASDAQ:AMD) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $200.00 price target on the stock. This represents a 39.5% upside from the current price of $143.41. Carlyle Group (NASDAQ:CG) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock, up previously from $44.00. This represents a 12.8% upside from the current price of $57.65. DAQO New Energy (NYSE:DQ) was upgraded by analysts at Glj Research from a "sell" rating to a "buy" rating. They now have a $30.51 price target on the stock. This represents a 51.4% upside from the current price of $20.15. Huntington Ingalls Industries (NYSE:HII) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $300.00 price target on the stock, up previously from $250.00. This represents a 18.9% upside from the current price of $252.30. McDonald's (NYSE:MCD) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $345.00 price target on the stock. This represents a 15.0% upside from the current price of $299.95. National Health Investors (NYSE:NHI) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $80.00 price target on the stock. This represents a 11.8% upside from the current price of $71.58. Oracle (NYSE:ORCL) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $270.00 price target on the stock, up previously from $190.00. This represents a 14.7% upside from the current price of $235.38. Piper Sandler Companies (NYSE:PIPR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $339.00 price target on the stock. This represents a 12.8% upside from the current price of $300.40. Synovus Financial (NYSE:SNV) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $62.00 price target on the stock, up previously from $50.00. This represents a 12.9% upside from the current price of $54.94. Trex (NYSE:TREX) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $75.00 price target on the stock, up previously from $65.00. This represents a 18.8% upside from the current price of $63.12. Zebra Technologies (NASDAQ:ZBRA) was upgraded by analysts at BNP Paribas Exane from a "neutral" rating to an "outperform" rating. They now have a $408.00 price target on the stock. This represents a 23.9% upside from the current price of $329.42. View More Upgrades Private trading room opens to 50 people (exclusive) (ad) What if you could sit in on a real trading desk — watching 8 pros call the markets live, every day? For the first time ever, this bell-to-bell trading room is opening to 50 new participants under a bold promise: watch first, then pay whatever you think it's worth. No hype. Just real trades, real education… and your call on the value.   Request your live trading room invitation here Analysts' Downgrades Centene (NYSE:CNC) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $33.00 price target on the stock, down previously from $70.00. This represents a 0.4% downside from the current price of $33.13. Columbia Banking System (NASDAQ:COLB) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $27.00 price target on the stock, down previously from $29.00. This represents a 7.2% upside from the current price of $25.20. Labcorp (NYSE:LH) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $260.00 price target on the stock. This represents a 0.7% upside from the current price of $258.11. MFA Financial (NYSE:MFA) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $10.00 price target on the stock. This represents a 4.8% upside from the current price of $9.55. Molina Healthcare (NYSE:MOH) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $266.00 price target on the stock, down previously from $364.00. This represents a 14.3% upside from the current price of $232.68. NIKE (NYSE:NKE) was downgraded by analysts at DZ Bank AG from a "buy" rating to a "hold" rating. They now have a $76.00 price target on the stock. This represents a 1.8% upside from the current price of $74.68. RenaissanceRe (NYSE:RNR) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $269.00 price target on the stock, up previously from $267.00. This represents a 12.9% upside from the current price of $238.16. Redwood Trust (NYSE:RWT) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $6.50 price target on the stock. This represents a 7.9% upside from the current price of $6.03. Sandstorm Gold (NYSE:SAND) was downgraded by analysts at TD Securities from a "buy" rating to a "sell" rating.The current price is $9.73. TFI International (NYSE:TFII) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating.The current price is $92.76. TKO Group (NYSE:TKO) was downgraded by analysts at Northcoast Research from a "buy" rating to a "neutral" rating.The current price is $170.94. UWM (NYSE:UWMC) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $4.50 price target on the stock. This represents a 9.4% upside from the current price of $4.12. Warby Parker (NYSE:WRBY) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.The current price is $21.70. View More Downgrades Strange pattern appears at 9:26 AM (Nasdaq traders are getting rich) (ad) I've discovered something about the Nasdaq that most traders will never know exists. It's a strange pattern that occurs around a specific number - 26. When price touches certain "26 levels" (like 17,026, 17,126, or 17,226), something remarkable happens nearly 90% of the time - the price bounces and reverses upward. After analyzing over 15 years of data and 1,100+ occurrences, I've documented how this pattern has consistently produced gains averaging $620 per trade, often in just minutes.   I've put everything I've discovered into a free report called "The Perfect Nasdaq Trade." Analysts' New Coverage Analog Devices (NASDAQ:ADI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $285.00 price target on the stock. This represents a 16.4% upside from the current price of $244.81. Automatic Data Processing (NASDAQ:ADP) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $340.00 price target on the stock. This represents a 10.3% upside from the current price of $308.24. Altimmune (NASDAQ:ALT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $1.00 price target on the stock. This represents a 77.1% downside from the current price of $4.38. Applied Materials (NASDAQ:AMAT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $225.00 price target on the stock. This represents a 13.5% upside from the current price of $198.16. Advanced Micro Devices (NASDAQ:AMD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $140.00 price target on the stock. This represents a 2.4% downside from the current price of $143.41. Amkor Technology (NASDAQ:AMKR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $20.00 price target on the stock. This represents a 9.2% downside from the current price of $22.03. Amylyx Pharmaceuticals (NASDAQ:AMLX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $10.00 price target on the stock. This represents a 36.9% upside from the current price of $7.30. ANI Pharmaceuticals (NASDAQ:ANIP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $84.00 price target on the stock. This represents a 28.4% upside from the current price of $65.43. ARM (NASDAQ:ARM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $160.00 price target on the stock. This represents a 8.5% upside from the current price of $147.44. ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $33.00 price target on the stock. This represents a 54.5% upside from the current price of $21.37. Broadcom (NASDAQ:AVGO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $315.00 price target on the stock. This represents a 15.0% upside from the current price of $274.03. Burke & Herbert Financial Services (NASDAQ:BHRB) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $70.00 price target on the stock. This represents a 7.6% upside from the current price of $65.09. Cadence Design Systems (NASDAQ:CDNS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $380.00 price target on the stock. This represents a 18.5% upside from the current price of $320.74. CG Oncology (NASDAQ:CGON) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $40.00 price target on the stock. This represents a 49.7% upside from the current price of $26.72. Cinemark (NYSE:CNK) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $36.00 price target on the stock. This represents a 22.4% upside from the current price of $29.42. Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $36.00 price target on the stock. This represents a 15.0% upside from the current price of $31.29. Equifax (NYSE:EFX) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $280.00 price target on the stock. This represents a 5.4% upside from the current price of $265.77. Estee Lauder Companies (NYSE:EL) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $110.00 price target on the stock. This represents a 20.8% upside from the current price of $91.06. Entegris (NASDAQ:ENTG) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $85.00 price target on the stock. This represents a 3.4% downside from the current price of $88.02. Equinix (NASDAQ:EQIX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $933.00 price target on the stock. This represents a 23.2% upside from the current price of $757.58. Geron (NASDAQ:GERN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $1.00 price target on the stock. This represents a 28.3% downside from the current price of $1.40. GlobalFoundries (NASDAQ:GFS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $40.00 price target on the stock. This represents a 3.2% downside from the current price of $41.33. Halozyme Therapeutics (NASDAQ:HALO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $55.00 price target on the stock. This represents a 3.7% downside from the current price of $57.11. Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $33.00 price target on the stock. This represents a 5.3% downside from the current price of $34.86. IDEAYA Biosciences (NASDAQ:IDYA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $25.00 price target on the stock. This represents a 11.7% upside from the current price of $22.39. Immunovant (NASDAQ:IMVT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $18.00 price target on the stock. This represents a 5.3% upside from the current price of $17.09. KLA (NASDAQ:KLAC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $980.00 price target on the stock. This represents a 5.8% upside from the current price of $926.00. Lam Research (NASDAQ:LRCX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $115.00 price target on the stock. This represents a 14.1% upside from the current price of $100.79. Microchip Technology (NASDAQ:MCHP) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $88.00 price target on the stock. This represents a 14.7% upside from the current price of $76.73. MKS (NASDAQ:MKSI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $90.00 price target on the stock. This represents a 15.8% downside from the current price of $106.89. Marvell Technology (NASDAQ:MRVL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $75.00 price target on the stock. This represents a 3.9% upside from the current price of $72.18. Micron Technology (NASDAQ:MU) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $150.00 price target on the stock. This represents a 22.0% upside from the current price of $122.99. Micron Technology (NASDAQ:MU) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $130.00 price target on the stock. This represents a 5.7% upside from the current price of $122.99. Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $182.00 price target on the stock. This represents a 35.8% upside from the current price of $134.04. Nano Nuclear Energy (NASDAQ:NNE) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $51.00 price target on the stock. This represents a 46.5% upside from the current price of $34.80. NAPCO Security Technologies (NASDAQ:NSSC) is now covered by analysts at Mizuho. They set an "outperform" rating and a $39.00 price target on the stock. This represents a 24.6% upside from the current price of $31.30. NVIDIA (NASDAQ:NVDA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $185.00 price target on the stock. This represents a 13.7% upside from the current price of $162.67. NXP Semiconductors (NASDAQ:NXPI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $276.00 price target on the stock. This represents a 18.3% upside from the current price of $233.35. ON Semiconductor (NASDAQ:ON) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $60.00 price target on the stock. This represents a 1.4% upside from the current price of $59.20. Paychex (NASDAQ:PAYX) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $160.00 price target on the stock. This represents a 9.9% upside from the current price of $145.57. Performant Healthcare (NASDAQ:PHLT) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $8.00 price target on the stock. This represents a 82.2% upside from the current price of $4.39. Performant Healthcare (NASDAQ:PHLT) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $8.00 price target on the stock. This represents a 82.2% upside from the current price of $4.39. Qorvo (NASDAQ:QRVO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $90.00 price target on the stock. This represents a 0.6% downside from the current price of $90.55. Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $55.00 price target on the stock. This represents a 82.1% upside from the current price of $30.21. Roivant Sciences (NASDAQ:ROIV) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $19.00 price target on the stock. This represents a 68.8% upside from the current price of $11.26. Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $97.00 price target on the stock. This represents a 9.7% upside from the current price of $88.42. Sandisk (NASDAQ:SNDK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $55.00 price target on the stock. This represents a 19.0% upside from the current price of $46.20. Syndax Pharmaceuticals (NASDAQ:SNDX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $18.00 price target on the stock. This represents a 93.1% upside from the current price of $9.32. Synopsys (NASDAQ:SNPS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $620.00 price target on the stock. This represents a 12.6% upside from the current price of $550.83. Seagate Technology (NASDAQ:STX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $170.00 price target on the stock. This represents a 18.7% upside from the current price of $143.21. Skyworks Solutions (NASDAQ:SWKS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $70.00 price target on the stock. This represents a 9.9% downside from the current price of $77.69. Teradyne (NASDAQ:TER) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $80.00 price target on the stock. This represents a 17.1% downside from the current price of $96.51. TG Therapeutics (NASDAQ:TGTX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $37.00 price target on the stock. This represents a 1.9% downside from the current price of $37.73. Transcat (NASDAQ:TRNS) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $105.00 price target on the stock. This represents a 19.0% upside from the current price of $88.21. Texas Instruments (NASDAQ:TXN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $255.00 price target on the stock. This represents a 16.3% upside from the current price of $219.24. Western Digital (NASDAQ:WDC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $130.00 price target on the stock. This represents a 99.0% upside from the current price of $65.34. View More New Coverage Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Earnings Conference Calls Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Stock Splits Unusual Options Volume Unusual Trading Volume Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. Upgrade Now Manage Your Watchlist View and add up to ten holdings to your watchlist. View My Portfolio Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. Join Now Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2025 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: ​9 AI Stocks Set to Soar Amid U.S.-China Trade Tensions (Click to Opt-In)

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: